Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy (mylehaplo)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00796562
First received: November 20, 2008
Last updated: September 29, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)